Everest Medicines Limited
雲頂新耀有限公司

09 OCT 2020

Everest Medicines Limited is a biopharmaceutical company focused on developing and commercializing potentially novel or differentiated therapies that address critical unmet medical needs for patients in Greater China and other emerging Asia Pacific markets. The management team of Everest Medicines has deep expertise and an extensive track record. Everest Medicines has built a portfolio of eight potentially globally first-in-class or best-in-class therapies, many of which are in late stage clinical development. The Company’s therapeutic areas of interest include oncology, immunology, cardio-renal disease and infectious disease.

雲頂新耀有限公司是一家專注于潛在的新穎首創或與眾不同之療法的研發及商業化的生物製藥公司，致力於滿足大中華區及亞太區其他新興市場未被滿足的醫療需求，其管理團隊均擁有深厚的專長和豐富的經驗。雲頂新耀已經建立了八種潛在全球首創或同類領先的療法，其中許多都處於臨床研發的後期階段。公司專注的治療領域包括腫瘤、免疫學、心腎疾病和感染性疾病。